Assertio Holdings, Inc. financial data

Symbol
ASRT on Nasdaq
Industry
Pharmaceutical Preparations
Location
100 S. Saunders Road, Suite 300, Lake Forest, IL
State of incorporation
DE
Fiscal year end
December 31
Former names
Assertio Therapeutics, Inc (to 5/10/2019), DEPOMED INC (to 5/26/2016), DEPOMED INC (to 5/26/2016)
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 191 % +24.4%
Quick Ratio 42.1 % +76.8%
Debt-to-equity 110 % +47.3%
Return On Equity -51.2 % +36.5%
Return On Assets -24.4 % +47.1%
Operating Margin -34.5 % +70.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 95.5M shares +0.86%
Common Stock, Shares, Outstanding 95.4M shares +0.85%
Entity Public Float 296M USD +111%
Common Stock, Value, Issued 9K USD 0%
Weighted Average Number of Shares Outstanding, Basic 95.4M shares +16.7%
Weighted Average Number of Shares Outstanding, Diluted 95.4M shares +16.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 126M USD -25.8%
Research and Development Expense 3.56M USD -23.6%
Costs and Expenses 169M USD -54.3%
Operating Income (Loss) -43.3M USD +78.4%
Nonoperating Income (Expense) 646K USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -42.7M USD +80%
Income Tax Expense (Benefit) 25.8M USD -99.9%
Net Income (Loss) Attributable to Parent -68.5M USD +63.2%
Earnings Per Share, Basic -1.45 USD/shares +1.36%
Earnings Per Share, Diluted -1.43 USD/shares +19.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 38M USD -50.6%
Accounts Receivable, after Allowance for Credit Loss, Current 44.9M USD -28.1%
Inventory, Net 39.8M USD -6.84%
Other Assets, Current 319K USD +13.5%
Assets, Current 181M USD -2.06%
Deferred Income Tax Assets, Net 0 USD -100%
Property, Plant and Equipment, Net 624K USD -22.4%
Operating Lease, Right-of-Use Asset 1.16M USD -35.7%
Intangible Assets, Net (Excluding Goodwill) 92.4M USD -45.8%
Goodwill 19.9M USD
Other Assets, Noncurrent 1.86M USD -53.4%
Assets 276M USD -27.4%
Accounts Payable, Current 13.2M USD -30.8%
Employee-related Liabilities, Current 2.47M USD +0.2%
Accrued Liabilities, Current 13M USD -41.2%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 90.1M USD -21.2%
Operating Lease, Liability, Noncurrent 1.18M USD -29.6%
Other Liabilities, Noncurrent 16.5M USD -7.62%
Liabilities 145M USD -22.3%
Retained Earnings (Accumulated Deficit) -663M USD -11.5%
Stockholders' Equity Attributable to Parent 131M USD -32.3%
Liabilities and Equity 276M USD -27.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 7.51M USD -67%
Net Cash Provided by (Used in) Financing Activities -206K USD +98.9%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 95.4M shares +0.85%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 7.3M USD +99.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 38M USD -50.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.3M USD -44.7%
Deferred Tax Assets, Valuation Allowance 316M USD +2427%
Deferred Tax Assets, Gross 317M USD +200%
Operating Lease, Liability 1.69M USD -36.3%
Depreciation 400K USD -50%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -333M USD -443%
Lessee, Operating Lease, Liability, to be Paid 2.83M USD +571%
Property, Plant and Equipment, Gross 3.98M USD -24.9%
Operating Lease, Liability, Current 505K USD -47.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 412K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 1.07M USD +155%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure -45%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 428K USD +2040%
Lessee, Operating Lease, Liability, to be Paid, Year Three 307K USD
Deferred Tax Assets, Operating Loss Carryforwards 245M USD +260%
Unrecognized Tax Benefits 7.74M USD +88.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 243K USD
Operating Lease, Payments 1.08M USD +31.6%
Additional Paid in Capital 793M USD +0.78%
Amortization of Intangible Assets 23.7M USD -23.2%
Depreciation, Depletion and Amortization 5.7M USD -12.2%
Deferred Tax Assets, Net of Valuation Allowance 367K USD -99.6%
Interest Expense 6.76M USD -31.5%